CGI Pharmaceuticals Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 38

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $120M

CGI Pharmaceuticals General Information

Description

Developer of small molecule therapeutics for multiple oncology and immunology-based indications. The company provides drug discovery and development programs, including Btk, a B-cell kinase for a range of AAID and oncology indications and Syk, a regulator of mast cell, monocyte, macrophage and B-cell functions.

Contact Information

Website
cgipharma.com
Formerly Known As
Cellular Genomics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 36 East Industrial Road
  • Branford, CT 06405
  • United States
+1 (203) 000-0000
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Gilead Sciences
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 36 East Industrial Road
  • Branford, CT 06405
  • United States
+1 (203) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CGI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 28-Jun-2010 $120M 0000 00000 Completed Clinical Trials - General
4. Later Stage VC (Series C) 21-Apr-2004 000.00 0000 00000 Completed Clinical Trials - General
3. Early Stage VC (Series B) 07-May-2001 0000 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Jan-2000 $3.1M $3.1M Completed Product Development
1. Seed Round 01-Jan-1998 Completed Startup
To view CGI Pharmaceuticals’s complete valuation and funding history, request access »

CGI Pharmaceuticals Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

CGI Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2003270489-A1 6-aryl-imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof Inactive 09-Sep-2002 0000000000
AU-2003245669-A1 Certain aromatic monocycles as kinase modulators Inactive 21-Jun-2002 0000000000
EP-1509526-A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof Inactive 19-Apr-2002 0000000000
US-20030165479-A1 Generating antibodies; modulation polypeptide; adjusting gene expression Inactive 19-Mar-2001 G01N33/5047 0

CGI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CGI Pharmaceuticals Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
CHL Medical Partners Venture Capital Minority 000 0000 000000 0
Coastview Capital Venture Capital Minority 000 0000 000000 0
Connecticut Innovations Venture Capital Minority 000 0000 000000 0
Emerging Technology Partners (Venture Capital) Corporate Venture Capital Minority 000 0000 000000 0
Flagship Pioneering Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

CGI Pharmaceuticals FAQs

  • When was CGI Pharmaceuticals founded?

    CGI Pharmaceuticals was founded in 1998.

  • Who is the founder of CGI Pharmaceuticals?

    Mark Velleca Ph.D is the founder of CGI Pharmaceuticals.

  • Where is CGI Pharmaceuticals headquartered?

    CGI Pharmaceuticals is headquartered in Branford, CT.

  • What is the size of CGI Pharmaceuticals?

    CGI Pharmaceuticals has 38 total employees.

  • What industry is CGI Pharmaceuticals in?

    CGI Pharmaceuticals’s primary industry is Drug Discovery.

  • Is CGI Pharmaceuticals a private or public company?

    CGI Pharmaceuticals is a Private company.

  • What is the current valuation of CGI Pharmaceuticals?

    The current valuation of CGI Pharmaceuticals is 00000.

  • What is CGI Pharmaceuticals’s current revenue?

    The current revenue for CGI Pharmaceuticals is 000000.

  • How much funding has CGI Pharmaceuticals raised over time?

    CGI Pharmaceuticals has raised $60M.

  • Who are CGI Pharmaceuticals’s investors?

    CHL Medical Partners, Coastview Capital, Connecticut Innovations, Emerging Technology Partners (Venture Capital), and Flagship Pioneering are 5 of 14 investors who have invested in CGI Pharmaceuticals.

  • When was CGI Pharmaceuticals acquired?

    CGI Pharmaceuticals was acquired on 28-Jun-2010.

  • Who acquired CGI Pharmaceuticals?

    CGI Pharmaceuticals was acquired by Gilead Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »